|
Missouri
|
|
45-3355106
|
(State or other jurisdiction of
incorporation or organization)
|
|
(I.R.S. Employer Identification No.)
|
Large accelerated filer
x
|
Accelerated filer
o
|
Non-accelerated filer
o
|
Smaller reporting company
o
|
|
Emerging growth company
o
|
|
|
|
Page
|
PART I.
|
|
|
|
|
|
Item 1.
|
||
|
|
|
|
||
|
|
|
|
||
|
|
|
|
||
|
|
|
|
||
|
|
|
|
||
|
|
|
|
||
|
|
|
Item 2.
|
||
|
|
|
Item 3.
|
||
|
|
|
Item 4.
|
||
|
|
|
PART II.
|
|
|
|
|
|
Item 1.
|
||
|
|
|
Item 1A.
|
||
|
|
|
Item 2.
|
||
|
|
|
Item 6.
|
||
|
|
|
|
|
Three Months Ended
December 31, |
||||||
|
2018
|
|
2017
|
||||
Net Sales
|
$
|
1,411.3
|
|
|
$
|
1,433.1
|
|
Cost of goods sold
|
984.8
|
|
|
984.6
|
|
||
Gross Profit
|
426.5
|
|
|
448.5
|
|
||
Selling, general and administrative expenses
|
217.1
|
|
|
246.0
|
|
||
Amortization of intangible assets
|
40.3
|
|
|
41.5
|
|
||
Gain on sale of business
|
(124.7
|
)
|
|
—
|
|
||
Other operating income, net
|
(0.1
|
)
|
|
—
|
|
||
Operating Profit
|
293.9
|
|
|
161.0
|
|
||
Interest expense, net
|
59.4
|
|
|
90.5
|
|
||
Loss on extinguishment of debt, net
|
6.1
|
|
|
37.3
|
|
||
Expense (income) on swaps, net
|
51.7
|
|
|
(2.7
|
)
|
||
Other income, net
|
(3.7
|
)
|
|
(3.5
|
)
|
||
Earnings before Income Taxes and Equity Method Loss
|
180.4
|
|
|
39.4
|
|
||
Income tax expense (benefit)
|
43.8
|
|
|
(255.8
|
)
|
||
Equity method loss, net of tax
|
10.7
|
|
|
—
|
|
||
Net Earnings Including Noncontrolling Interest
|
125.9
|
|
|
295.2
|
|
||
Less: Net earnings attributable to noncontrolling interest
|
0.3
|
|
|
0.3
|
|
||
Net Earnings
|
125.6
|
|
|
294.9
|
|
||
Less: Preferred stock dividends
|
2.0
|
|
|
3.4
|
|
||
Net Earnings Available to Common Shareholders
|
$
|
123.6
|
|
|
$
|
291.5
|
|
|
|
|
|
||||
Earnings per Common Share:
|
|
|
|
||||
Basic
|
$
|
1.85
|
|
|
$
|
4.42
|
|
Diluted
|
$
|
1.67
|
|
|
$
|
3.82
|
|
|
|
|
|
||||
Weighted-Average Common Shares Outstanding:
|
|
|
|
||||
Basic
|
66.7
|
|
|
66.0
|
|
||
Diluted
|
75.1
|
|
|
77.3
|
|
|
Three Months Ended
December 31, |
||||||
|
2018
|
|
2017
|
||||
Net Earnings Including Noncontrolling Interest
|
$
|
125.9
|
|
|
$
|
295.2
|
|
Pension and postretirement benefits adjustments:
|
|
|
|
||||
Reclassifications to net earnings
|
(1.2
|
)
|
|
(0.8
|
)
|
||
Hedging adjustments:
|
|
|
|
||||
Unrealized net gain (loss) on derivatives
|
24.4
|
|
|
(1.5
|
)
|
||
Reclassifications to net earnings
|
(30.1
|
)
|
|
0.3
|
|
||
Foreign currency translation adjustments:
|
|
|
|
||||
Unrealized foreign currency translation adjustments
|
(40.2
|
)
|
|
13.9
|
|
||
Reclassifications to net earnings
|
42.1
|
|
|
—
|
|
||
Tax benefit on other comprehensive income:
|
|
|
|
||||
Pension and postretirement benefits
|
0.3
|
|
|
0.2
|
|
||
Hedging
|
1.4
|
|
|
0.3
|
|
||
Total Other Comprehensive (Loss) Income
|
(3.3
|
)
|
|
12.4
|
|
||
Less: Comprehensive income attributable to noncontrolling interest
|
0.3
|
|
|
0.3
|
|
||
Total Comprehensive Income
|
$
|
122.3
|
|
|
$
|
307.3
|
|
|
December 31, 2018
|
|
September 30, 2018
|
||||
ASSETS
|
|||||||
Current Assets
|
|
|
|
||||
Cash and cash equivalents
|
$
|
222.9
|
|
|
$
|
989.7
|
|
Restricted cash
|
10.6
|
|
|
4.8
|
|
||
Receivables, net
|
452.5
|
|
|
462.3
|
|
||
Inventories
|
498.9
|
|
|
484.2
|
|
||
Current assets held for sale
|
—
|
|
|
195.0
|
|
||
Prepaid expenses and other current assets
|
57.5
|
|
|
64.3
|
|
||
Total Current Assets
|
1,242.4
|
|
|
2,200.3
|
|
||
Property, net
|
1,715.0
|
|
|
1,709.7
|
|
||
Goodwill
|
4,478.5
|
|
|
4,499.6
|
|
||
Other intangible assets, net
|
3,488.8
|
|
|
3,539.3
|
|
||
Equity method investments
|
168.1
|
|
|
5.2
|
|
||
Other assets held for sale
|
—
|
|
|
856.6
|
|
||
Other assets
|
192.0
|
|
|
246.8
|
|
||
Total Assets
|
$
|
11,284.8
|
|
|
$
|
13,057.5
|
|
|
|
|
|
||||
LIABILITIES AND SHAREHOLDERS’ EQUITY
|
|||||||
Current Liabilities
|
|
|
|
||||
Current portion of long-term debt
|
$
|
3.4
|
|
|
$
|
22.1
|
|
Accounts payable
|
331.6
|
|
|
365.1
|
|
||
Current liabilities held for sale
|
—
|
|
|
65.6
|
|
||
Other current liabilities
|
462.1
|
|
|
339.3
|
|
||
Total Current Liabilities
|
797.1
|
|
|
792.1
|
|
||
Long-term debt
|
6,336.5
|
|
|
7,232.1
|
|
||
Deferred income taxes
|
781.2
|
|
|
778.4
|
|
||
Other liabilities held for sale
|
—
|
|
|
695.1
|
|
||
Other liabilities
|
213.6
|
|
|
499.3
|
|
||
Total Liabilities
|
8,128.4
|
|
|
9,997.0
|
|
||
|
|
|
|
||||
Shareholders’ Equity
|
|
|
|
||||
Preferred stock
|
—
|
|
|
—
|
|
||
Common stock
|
0.8
|
|
|
0.8
|
|
||
Additional paid-in capital
|
3,592.4
|
|
|
3,590.9
|
|
||
Retained earnings
|
210.7
|
|
|
88.0
|
|
||
Accumulated other comprehensive loss
|
(42.7
|
)
|
|
(39.4
|
)
|
||
Treasury stock, at cost
|
(615.2
|
)
|
|
(589.9
|
)
|
||
Total Shareholders’ Equity Excluding Noncontrolling Interest
|
3,146.0
|
|
|
3,050.4
|
|
||
Noncontrolling interest
|
10.4
|
|
|
10.1
|
|
||
Total Shareholders’ Equity
|
3,156.4
|
|
|
3,060.5
|
|
||
Total Liabilities and Shareholders’ Equity
|
$
|
11,284.8
|
|
|
$
|
13,057.5
|
|
|
Three Months Ended
December 31, |
||||||
|
2018
|
|
2017
|
||||
Cash Flows from Operating Activities
|
|
|
|
||||
Net Earnings Including Noncontrolling Interest
|
$
|
125.9
|
|
|
$
|
295.2
|
|
Adjustments to reconcile net earnings including noncontrolling interest to net cash flow provided by operating activities:
|
|
|
|
||||
Depreciation and amortization
|
93.6
|
|
|
90.5
|
|
||
Unrealized loss (gain) on interest rate swaps
|
51.5
|
|
|
(3.1
|
)
|
||
Gain on sale of business
|
(124.7
|
)
|
|
—
|
|
||
Loss on extinguishment of debt, net
|
6.1
|
|
|
37.3
|
|
||
Non-cash stock-based compensation expense
|
8.7
|
|
|
6.8
|
|
||
Equity method loss, net of tax
|
10.7
|
|
|
—
|
|
||
Deferred income taxes
|
8.1
|
|
|
(262.7
|
)
|
||
Other, net
|
0.6
|
|
|
2.3
|
|
||
Other changes in operating assets and liabilities, net of business acquisitions:
|
|
|
|
||||
Decrease in receivables, net
|
30.8
|
|
|
11.6
|
|
||
Increase in inventories
|
(16.1
|
)
|
|
(13.4
|
)
|
||
Increase in prepaid expenses and other current assets
|
(0.5
|
)
|
|
(14.5
|
)
|
||
Decrease (increase) in other assets
|
0.9
|
|
|
(5.4
|
)
|
||
Increase in accounts payable and other current liabilities
|
46.7
|
|
|
61.9
|
|
||
Decrease in non-current liabilities
|
(3.6
|
)
|
|
(2.0
|
)
|
||
Net Cash Provided by Operating Activities
|
238.7
|
|
|
204.5
|
|
||
|
|
|
|
||||
Cash Flows from Investing Activities
|
|
|
|
||||
Additions to property
|
(78.8
|
)
|
|
(46.7
|
)
|
||
Proceeds from sale of property and assets held for sale
|
2.0
|
|
|
0.1
|
|
||
Proceeds from sale of business
|
250.0
|
|
|
—
|
|
||
Cross-currency swap cash settlements
|
28.3
|
|
|
—
|
|
||
Other, net
|
—
|
|
|
(1.2
|
)
|
||
Net Cash Provided by (Used in) Investing Activities
|
201.5
|
|
|
(47.8
|
)
|
||
|
|
|
|
||||
Cash Flows from Financing Activities
|
|
|
|
||||
Proceeds from issuance of long-term debt
|
—
|
|
|
1,000.0
|
|
||
Repayments of long-term debt
|
(919.0
|
)
|
|
(635.5
|
)
|
||
Payments to appraisal rights holders
|
(253.6
|
)
|
|
—
|
|
||
Purchases of treasury stock
|
(25.3
|
)
|
|
(56.0
|
)
|
||
Payments of preferred stock dividends
|
(2.0
|
)
|
|
(3.4
|
)
|
||
Payments of debt issuance costs
|
(0.3
|
)
|
|
(10.2
|
)
|
||
Refund of debt issuance costs
|
7.8
|
|
|
—
|
|
||
Payment of debt extinguishment costs
|
—
|
|
|
(30.8
|
)
|
||
Other, net
|
(7.2
|
)
|
|
(4.5
|
)
|
||
Net Cash (Used in) Provided by Financing Activities
|
(1,199.6
|
)
|
|
259.6
|
|
||
Effect of Exchange Rate Changes on Cash, Cash Equivalents and Restricted Cash
|
(1.6
|
)
|
|
0.7
|
|
||
Net (Decrease) Increase in Cash, Cash Equivalents and Restricted Cash
|
(761.0
|
)
|
|
417.0
|
|
||
Cash, Cash Equivalents and Restricted Cash, Beginning of Year
|
994.5
|
|
|
1,530.1
|
|
||
Cash, Cash Equivalents and Restricted Cash, End of Period
|
$
|
233.5
|
|
|
$
|
1,947.1
|
|
|
Post Holdings, Inc. Shareholders’
|
|
|
|
|
||||||||||||||||||||||||||||||||||||||||
|
Preferred Stock
|
|
Common Stock
|
|
|
|
|
|
Accumulated Other Comprehensive Loss
|
|
|
|
|
|
|
||||||||||||||||||||||||||||||
|
Shares
|
|
Amount
|
|
Shares
|
|
Amount
|
|
Additional Paid-in Capital
|
|
(Accumulated Deficit) Retained Earnings
|
|
Retirement Benefit Adjustments, net of tax
|
|
Hedging Adjustments, net of tax
|
|
Foreign Currency Translation Adjustments
|
|
Treasury Stock
|
|
Non-Controlling Interest
|
|
Total Shareholders’ Equity
|
||||||||||||||||||||||
Balance, September 30, 2017
|
4.7
|
|
|
$
|
—
|
|
|
66.1
|
|
|
$
|
0.7
|
|
|
$
|
3,566.5
|
|
|
$
|
(376.0
|
)
|
|
$
|
35.1
|
|
|
$
|
(11.1
|
)
|
|
$
|
(64.0
|
)
|
|
$
|
(371.2
|
)
|
|
$
|
9.7
|
|
|
$
|
2,789.7
|
|
Net earnings
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
294.9
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
294.9
|
|
||||||||||
Preferred stock dividends declared
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(3.4
|
)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(3.4
|
)
|
||||||||||
Activity under stock and deferred compensation plans
|
—
|
|
|
—
|
|
|
0.1
|
|
|
—
|
|
|
(4.3
|
)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(4.3
|
)
|
||||||||||
Stock-based compensation expense
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
6.8
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
6.8
|
|
||||||||||
Purchases of treasury stock
|
—
|
|
|
—
|
|
|
(0.7
|
)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(56.0
|
)
|
|
—
|
|
|
(56.0
|
)
|
||||||||||
Net earnings attributable to noncontrolling interest
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
0.3
|
|
|
0.3
|
|
||||||||||
Net change in retirement benefits, net of tax
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(0.6
|
)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(0.6
|
)
|
||||||||||
Net change in hedges, net of tax
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(0.9
|
)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(0.9
|
)
|
||||||||||
Foreign currency translation adjustments
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
13.9
|
|
|
—
|
|
|
—
|
|
|
13.9
|
|
||||||||||
Balance, December 31, 2017
|
4.7
|
|
|
$
|
—
|
|
|
65.5
|
|
|
$
|
0.7
|
|
|
$
|
3,565.6
|
|
|
$
|
(81.1
|
)
|
|
$
|
34.5
|
|
|
$
|
(12.0
|
)
|
|
$
|
(50.1
|
)
|
|
$
|
(427.2
|
)
|
|
$
|
10.0
|
|
|
$
|
3,040.4
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||||||||
Balance, September 30, 2018
|
3.2
|
|
|
$
|
—
|
|
|
66.7
|
|
|
$
|
0.8
|
|
|
$
|
3,590.9
|
|
|
$
|
88.0
|
|
|
$
|
37.9
|
|
|
$
|
37.4
|
|
|
$
|
(114.7
|
)
|
|
$
|
(589.9
|
)
|
|
$
|
10.1
|
|
|
$
|
3,060.5
|
|
Net earnings
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
125.6
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
125.6
|
|
||||||||||
Adoption of accounting standards update 2014-09
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(0.9
|
)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(0.9
|
)
|
||||||||||
Preferred stock dividends declared
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(2.0
|
)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(2.0
|
)
|
||||||||||
Activity under stock and deferred compensation plans
|
—
|
|
|
—
|
|
|
0.2
|
|
|
—
|
|
|
(7.2
|
)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(7.2
|
)
|
||||||||||
Stock-based compensation expense
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
8.7
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
8.7
|
|
||||||||||
Purchases of treasury stock
|
—
|
|
|
—
|
|
|
(0.3
|
)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(25.3
|
)
|
|
—
|
|
|
(25.3
|
)
|
||||||||||
Net earnings attributable to noncontrolling interest
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
0.3
|
|
|
0.3
|
|
||||||||||
Net change in retirement benefits, net of tax
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(0.9
|
)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(0.9
|
)
|
Net change in hedges, net of tax
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(4.3
|
)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(4.3
|
)
|
||||||||||
Foreign currency translation adjustments
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
1.9
|
|
|
—
|
|
|
—
|
|
|
1.9
|
|
||||||||||
Balance, December 31, 2018
|
3.2
|
|
|
$
|
—
|
|
|
66.6
|
|
|
$
|
0.8
|
|
|
$
|
3,592.4
|
|
|
$
|
210.7
|
|
|
$
|
37.0
|
|
|
$
|
33.1
|
|
|
$
|
(112.8
|
)
|
|
$
|
(615.2
|
)
|
|
$
|
10.4
|
|
|
$
|
3,156.4
|
|
•
|
Significant financing component
— The Company elected not to adjust the promised amount of consideration for the effects of a significant financing component as the Company expects, at contract inception, the period between the transfer of a promised good or service to a customer and when the customer pays for that good or service will be one year or less.
|
•
|
Shipping and handling costs
— The Company elected to account for shipping and handling activities that occur before the customer has obtained control of a good as fulfillment activities (i.e., an expense), rather than as a promised service.
|
•
|
Measurement of transaction price
— The Company elected to exclude from the measurement of transaction price all taxes assessed by a governmental authority that are both imposed on and concurrent with a specific revenue-producing transaction and collected by the Company from a customer for sales taxes.
|
|
Three Months Ended December 31, 2018
|
||||||||||
|
As Reported Under Topic 606
|
|
As Reported Under Prior Guidance
|
|
Impact of Adoption
|
||||||
Net Sales
|
$
|
1,411.3
|
|
|
$
|
1,415.6
|
|
|
$
|
(4.3
|
)
|
Cost of goods sold
|
984.8
|
|
|
984.8
|
|
|
—
|
|
|||
Gross Profit
|
426.5
|
|
|
430.8
|
|
|
(4.3
|
)
|
|||
Selling, general and administrative expenses
|
217.1
|
|
|
221.8
|
|
|
(4.7
|
)
|
|||
Amortization of intangible assets
|
40.3
|
|
|
40.3
|
|
|
—
|
|
|||
Gain on sale of business
|
(124.7
|
)
|
|
(124.7
|
)
|
|
—
|
|
|||
Other operating income, net
|
(0.1
|
)
|
|
(0.1
|
)
|
|
—
|
|
|||
Operating Profit
|
$
|
293.9
|
|
|
$
|
293.5
|
|
|
$
|
0.4
|
|
|
Three Months Ended
December 31, |
||||||
|
2018
|
|
2017
|
||||
Cereal and granola
|
$
|
556.2
|
|
|
$
|
555.7
|
|
Egg and egg products
|
394.7
|
|
|
381.1
|
|
||
Cheese and dairy
|
70.3
|
|
|
71.7
|
|
||
Side dishes
|
145.7
|
|
|
56.2
|
|
||
Sausage
|
43.6
|
|
|
—
|
|
||
Pasta
|
—
|
|
|
67.6
|
|
||
Protein-based products and supplements
|
185.8
|
|
|
186.0
|
|
||
Nut butters and dried fruit and nut
|
—
|
|
|
114.3
|
|
||
Other
|
15.4
|
|
|
1.6
|
|
||
Eliminations
|
(0.4
|
)
|
|
(1.1
|
)
|
||
Net Sales
|
$
|
1,411.3
|
|
|
$
|
1,433.1
|
|
|
Acquisition Date Amounts Recognized as of September 30, 2018 (a)
|
|
Adjustments During the Three Months Ended December 31, 2018
|
|
Acquisition Date Amounts Recognized (as Adjusted)
|
||||||
Cash and cash equivalents
|
$
|
15.6
|
|
|
$
|
—
|
|
|
$
|
15.6
|
|
Receivables
|
58.5
|
|
|
—
|
|
|
58.5
|
|
|||
Inventories
|
27.1
|
|
|
—
|
|
|
27.1
|
|
|||
Prepaid expenses and other current assets
|
34.3
|
|
|
—
|
|
|
34.3
|
|
|||
Property
|
184.3
|
|
|
—
|
|
|
184.3
|
|
|||
Goodwill
|
898.3
|
|
|
(0.7
|
)
|
|
897.6
|
|
|||
Other intangible assets
|
782.0
|
|
|
—
|
|
|
782.0
|
|
|||
Other assets
|
0.4
|
|
|
—
|
|
|
0.4
|
|
|||
Accounts payable
|
(18.2
|
)
|
|
—
|
|
|
(18.2
|
)
|
|||
Other current liabilities
|
(58.5
|
)
|
|
—
|
|
|
(58.5
|
)
|
|||
Deferred tax liability - long-term
|
(194.9
|
)
|
|
0.7
|
|
|
(194.2
|
)
|
|||
Other liabilities
|
(5.3
|
)
|
|
—
|
|
|
(5.3
|
)
|
|||
Total acquisition cost
|
$
|
1,723.6
|
|
|
$
|
—
|
|
|
$
|
1,723.6
|
|
|
Three Months Ended
December 31, |
||||||
|
2018
|
|
2017
|
||||
Pro forma net sales
|
$
|
1,411.3
|
|
|
$
|
1,379.4
|
|
Pro forma net earnings available to common shareholders
|
$
|
38.9
|
|
|
$
|
263.1
|
|
Pro forma basic earnings per common share
|
$
|
0.58
|
|
|
$
|
3.99
|
|
Pro forma diluted earnings per common share
|
$
|
0.54
|
|
|
$
|
3.45
|
|
|
Employee-Related Costs
|
|
Accelerated Depreciation
|
|
Total
|
||||||
Balance, September 30, 2018
|
$
|
2.7
|
|
|
$
|
—
|
|
|
$
|
2.7
|
|
Charge to expense
|
0.7
|
|
|
1.8
|
|
|
2.5
|
|
|||
Cash payments
|
—
|
|
|
—
|
|
|
—
|
|
|||
Non-cash charges
|
—
|
|
|
(1.8
|
)
|
|
(1.8
|
)
|
|||
Balance, December 31, 2018
|
$
|
3.4
|
|
|
$
|
—
|
|
|
$
|
3.4
|
|
|
|
|
|
|
|
||||||
Total expected restructuring charge
|
$
|
5.7
|
|
|
$
|
11.2
|
|
|
$
|
16.9
|
|
Cumulative restructuring charges incurred to date
|
3.4
|
|
|
4.3
|
|
|
7.7
|
|
|||
Remaining expected restructuring charge
|
$
|
2.3
|
|
|
$
|
6.9
|
|
|
$
|
9.2
|
|
Current assets held for sale
|
|
||
Restricted cash
|
$
|
0.7
|
|
Receivables, net
|
79.8
|
|
|
Inventories
|
111.6
|
|
|
Prepaid expenses and other current assets
|
1.5
|
|
|
Property, net (a)
|
1.4
|
|
|
|
$
|
195.0
|
|
Other assets held for sale
|
|
||
Property, net (a)
|
$
|
165.1
|
|
Goodwill
|
417.1
|
|
|
Other intangible assets, net
|
270.4
|
|
|
Other assets
|
4.0
|
|
|
|
$
|
856.6
|
|
Current liabilities held for sale
|
|
||
Accounts payable
|
$
|
37.4
|
|
Other current liabilities
|
28.2
|
|
|
|
$
|
65.6
|
|
Other liabilities held for sale
|
|
||
Long-term debt
|
$
|
614.6
|
|
Deferred income taxes
|
79.9
|
|
|
Other liabilities
|
0.6
|
|
|
|
$
|
695.1
|
|
(a)
|
In accordance with ASC Topic 360, “Property, Plant, and Equipment,” the building classified as held for sale related to the closure of the Company’s Post Consumer Brands cereal warehouse in Clinton, Massachusetts and the 8th Avenue properties held for sale are classified as current and noncurrent, respectively, on the Condensed Consolidated Balance Sheet.
|
|
Post Consumer Brands
|
|
Weetabix
|
|
Foodservice
|
|
Refrigerated Retail
|
|
Active Nutrition
|
|
Total
|
||||||||||||
Balance, September 30, 2018
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
Goodwill (gross)
|
$
|
2,012.0
|
|
|
$
|
900.9
|
|
|
$
|
1,373.1
|
|
|
$
|
756.8
|
|
|
$
|
180.7
|
|
|
$
|
5,223.5
|
|
Accumulated impairment losses
|
(609.1
|
)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(114.8
|
)
|
|
(723.9
|
)
|
||||||
Goodwill (net)
|
$
|
1,402.9
|
|
|
$
|
900.9
|
|
|
$
|
1,373.1
|
|
|
$
|
756.8
|
|
|
$
|
65.9
|
|
|
$
|
4,499.6
|
|
Goodwill acquired
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
||||||
Acquisition related adjustment
|
—
|
|
|
—
|
|
|
(0.5
|
)
|
|
(0.2
|
)
|
|
—
|
|
|
(0.7
|
)
|
||||||
Currency translation adjustment
|
(0.3
|
)
|
|
(20.1
|
)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(20.4
|
)
|
||||||
Balance, December 31, 2018
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
Goodwill (gross)
|
$
|
2,011.7
|
|
|
$
|
880.8
|
|
|
$
|
1,372.6
|
|
|
$
|
756.6
|
|
|
$
|
180.7
|
|
|
$
|
5,202.4
|
|
Accumulated impairment losses
|
(609.1
|
)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(114.8
|
)
|
|
(723.9
|
)
|
||||||
Goodwill (net)
|
$
|
1,402.6
|
|
|
$
|
880.8
|
|
|
$
|
1,372.6
|
|
|
$
|
756.6
|
|
|
$
|
65.9
|
|
|
$
|
4,478.5
|
|
|
Three Months Ended
December 31, 2018 |
||
8th Avenue’s net loss available to 8th Avenue common shareholders
|
$
|
(11.5
|
)
|
|
60.5
|
%
|
|
Equity method loss available to Post’s common shareholders
|
$
|
(7.0
|
)
|
Less: Amortization of basis difference, net of tax (a)
|
3.6
|
|
|
Equity method loss, net of tax
|
$
|
(10.6
|
)
|
(a)
|
The Company adjusted the historical basis of 8th Avenue’s assets and liabilities to fair value and recognized a total basis difference of
$68.4
, which represents Post’s retained portion of the gain on sale. The basis difference related to inventory of
$2.0
, net of tax, was included in equity method loss in the three months ended December 31, 2018. The basis difference related to property, plant and equipment and other
|
|
Three Months Ended
December 31, 2018 |
||
Net sales
|
$
|
214.1
|
|
Gross profit
|
$
|
33.7
|
|
|
|
||
Net loss
|
$
|
(4.5
|
)
|
Preferred stock dividend
|
7.0
|
|
|
Net Loss Available to 8th Avenue Common Shareholders
|
$
|
(11.5
|
)
|
|
December 31, 2018
|
|
September 30, 2018
|
||||||||||||||||||||
|
Carrying
Amount |
|
Accumulated
Amortization
|
|
Net
Amount |
|
Carrying
Amount |
|
Accumulated
Amortization
|
|
Net
Amount |
||||||||||||
Subject to amortization:
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
Customer relationships
|
$
|
2,303.1
|
|
|
$
|
(473.9
|
)
|
|
$
|
1,829.2
|
|
|
$
|
2,307.0
|
|
|
$
|
(444.4
|
)
|
|
$
|
1,862.6
|
|
Trademarks and brands
|
814.6
|
|
|
(198.8
|
)
|
|
615.8
|
|
|
768.5
|
|
|
(188.2
|
)
|
|
580.3
|
|
||||||
Other intangible assets
|
3.1
|
|
|
(3.1
|
)
|
|
—
|
|
|
3.1
|
|
|
(3.1
|
)
|
|
—
|
|
||||||
|
3,120.8
|
|
|
(675.8
|
)
|
|
2,445.0
|
|
|
3,078.6
|
|
|
(635.7
|
)
|
|
2,442.9
|
|
||||||
Not subject to amortization:
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
Trademarks and brands
|
1,043.8
|
|
|
—
|
|
|
1,043.8
|
|
|
1,096.4
|
|
|
—
|
|
|
1,096.4
|
|
||||||
|
$
|
4,164.6
|
|
|
$
|
(675.8
|
)
|
|
$
|
3,488.8
|
|
|
$
|
4,175.0
|
|
|
$
|
(635.7
|
)
|
|
$
|
3,539.3
|
|
|
Three Months Ended
December 31, |
||||||
|
2018
|
|
2017
|
||||
Net earnings for basic earnings per share
|
$
|
123.6
|
|
|
$
|
291.5
|
|
Dilutive preferred stock dividends
|
2.0
|
|
|
3.4
|
|
||
Net earnings for diluted earnings per share
|
$
|
125.6
|
|
|
$
|
294.9
|
|
|
|
|
|
||||
Weighted-average shares for basic earnings per share
|
66.7
|
|
|
66.0
|
|
||
Effect of dilutive securities:
|
|
|
|
||||
Stock options
|
2.0
|
|
|
1.8
|
|
||
Stock appreciation rights
|
0.1
|
|
|
0.1
|
|
||
Restricted stock awards
|
0.4
|
|
|
0.4
|
|
||
Preferred shares conversion to common
|
5.9
|
|
|
9.0
|
|
||
Total dilutive securities
|
8.4
|
|
|
11.3
|
|
||
Weighted-average shares for diluted earnings per share
|
75.1
|
|
|
77.3
|
|
||
|
|
|
|
||||
Basic earnings per common share
|
$
|
1.85
|
|
|
$
|
4.42
|
|
Diluted earnings per common share
|
$
|
1.67
|
|
|
$
|
3.82
|
|
|
Three Months Ended
December 31, |
||||
|
2018
|
|
2017
|
||
Stock options
|
0.3
|
|
|
0.6
|
|
Restricted stock awards
|
0.2
|
|
|
—
|
|
Performance-based restricted stock awards
|
0.1
|
|
|
—
|
|
|
December 31,
2018 |
|
September 30,
2018 |
||||
Raw materials and supplies
|
$
|
98.2
|
|
|
$
|
107.8
|
|
Work in process
|
18.6
|
|
|
17.8
|
|
||
Finished products
|
348.5
|
|
|
324.1
|
|
||
Flocks
|
33.6
|
|
|
34.5
|
|
||
|
$
|
498.9
|
|
|
$
|
484.2
|
|
|
December 31,
2018 |
|
September 30,
2018 |
||||
Property, at cost
|
$
|
2,595.9
|
|
|
$
|
2,543.0
|
|
Accumulated depreciation
|
(880.9
|
)
|
|
(833.3
|
)
|
||
|
$
|
1,715.0
|
|
|
$
|
1,709.7
|
|
•
|
Commodity and energy futures and option contracts, which relate to inputs that generally will be utilized within the next year;
|
•
|
foreign currency forward contracts maturing within the next year that have the effect of hedging currency fluctuations between the Euro and the U.S. Dollar;
|
•
|
a pay-fixed, receive-variable interest rate swap maturing in May 2021 that requires monthly settlements and has the effect of hedging interest payments on debt expected to be issued but not yet priced; and
|
•
|
rate-lock interest rate swaps that require five lump sum settlements with the first settlement occurring in December 2019 and the last in July 2022 and have the effect of hedging interest payments on debt expected to be issued but not yet priced.
|
•
|
Pay-fixed, receive-fixed cross-currency swaps with maturities in July 2022 that require quarterly cash settlements and are used as net investment hedges of the Company’s investment in Weetabix, which is denominated in Pounds Sterling; and
|
•
|
a pay-fixed, receive-variable interest rate swap maturing in May 2024 that requires monthly settlements and is used as a cash flow hedge of forecasted interest payments on the Company’s variable rate term loan.
|
|
|
December 31,
2018 |
|
September 30,
2018 |
||||
Not designated as hedging instruments under ASC Topic 815:
|
|
|
|
|
||||
Commodity contracts
|
|
$
|
37.6
|
|
|
$
|
64.3
|
|
Energy contracts
|
|
62.7
|
|
|
20.8
|
|
||
Foreign exchange contracts - Forward contracts
|
|
6.8
|
|
|
9.3
|
|
||
Interest rate swap
|
|
74.2
|
|
|
74.6
|
|
||
Interest rate swaps - Rate-lock swaps
|
|
1,649.3
|
|
|
1,649.3
|
|
||
Designated as hedging instruments under ASC Topic 815:
|
|
|
|
|
||||
Foreign exchange contracts - Cross-currency swaps
|
|
448.7
|
|
|
662.9
|
|
||
Interest rate swap
|
|
200.0
|
|
|
1,000.0
|
|
|
|
|
|
Fair Value
|
|
Portion Designated as Hedging Instruments
|
||||||||||||
|
|
Balance Sheet Location
|
|
December 31,
2018 |
|
September 30,
2018 |
|
December 31,
2018 |
|
September 30,
2018 |
||||||||
Asset Derivatives:
|
|
|
|
|
|
|
|
|
|
|
||||||||
Commodity contracts
|
|
Prepaid expenses and other current assets
|
|
$
|
1.2
|
|
|
$
|
1.9
|
|
|
$
|
—
|
|
|
$
|
—
|
|
Energy contracts
|
|
Prepaid expenses and other current assets
|
|
0.7
|
|
|
4.9
|
|
|
—
|
|
|
—
|
|
||||
Commodity contracts
|
|
Other assets
|
|
—
|
|
|
0.2
|
|
|
—
|
|
|
—
|
|
||||
Energy contracts
|
|
Other assets
|
|
—
|
|
|
0.3
|
|
|
—
|
|
|
—
|
|
||||
Foreign exchange contracts
|
|
Prepaid expenses and other current assets
|
|
—
|
|
|
1.2
|
|
|
—
|
|
|
1.1
|
|
||||
Foreign exchange contracts
|
|
Other assets
|
|
—
|
|
|
17.6
|
|
|
—
|
|
|
17.6
|
|
||||
Interest rate swaps
|
|
Prepaid expenses and other current assets
|
|
0.4
|
|
|
6.4
|
|
|
0.4
|
|
|
6.4
|
|
||||
Interest rate swaps
|
|
Other assets
|
|
2.0
|
|
|
33.9
|
|
|
2.0
|
|
|
30.6
|
|
||||
|
|
|
|
$
|
4.3
|
|
|
$
|
66.4
|
|
|
$
|
2.4
|
|
|
$
|
55.7
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||
Liability Derivatives:
|
|
|
|
|
|
|
|
|
|
|
||||||||
Commodity contracts
|
|
Other current liabilities
|
|
$
|
0.4
|
|
|
$
|
2.2
|
|
|
$
|
—
|
|
|
$
|
—
|
|
Energy contracts
|
|
Other current liabilities
|
|
5.2
|
|
|
0.4
|
|
|
—
|
|
|
—
|
|
||||
Foreign exchange contracts
|
|
Other current liabilities
|
|
0.3
|
|
|
1.5
|
|
|
0.2
|
|
|
1.4
|
|
||||
Foreign exchange contracts
|
|
Other liabilities
|
|
1.3
|
|
|
19.4
|
|
|
1.3
|
|
|
19.4
|
|
||||
Interest rate swaps
|
|
Other current liabilities
|
|
68.4
|
|
|
23.6
|
|
|
—
|
|
|
—
|
|
||||
Interest rate swaps
|
|
Other liabilities
|
|
97.7
|
|
|
94.3
|
|
|
—
|
|
|
—
|
|
||||
|
|
|
|
$
|
173.3
|
|
|
$
|
141.4
|
|
|
$
|
1.5
|
|
|
$
|
20.8
|
|
Derivatives Not Designated as Hedging Instruments
|
|
Statement of Operations Location
|
|
(Gain) Loss Recognized in Statement of Operations
|
||||||
|
|
2018
|
|
2017
|
||||||
Commodity contracts
|
|
Cost of goods sold
|
|
$
|
(0.2
|
)
|
|
$
|
0.4
|
|
Energy contracts
|
|
Cost of goods sold
|
|
8.3
|
|
|
(2.2
|
)
|
||
Foreign exchange contracts
|
|
Selling, general and administrative expenses
|
|
—
|
|
|
0.2
|
|
||
Interest rate swaps
|
|
Expense (income) on swaps, net
|
|
51.7
|
|
|
(2.7
|
)
|
Derivatives Designated as Hedging Instruments
|
|
Loss (Gain) Recognized in OCI
|
|
(Gain) Loss Reclassified from Accumulated OCI into Earnings
|
|
Statement of Operations Location
|
||||||||||||
|
2018
|
|
2017
|
|
2018
|
|
2017
|
|
||||||||||
Foreign exchange contracts
|
|
$
|
—
|
|
|
$
|
(0.2
|
)
|
|
$
|
—
|
|
|
$
|
—
|
|
|
Selling, general and administrative expenses
|
Interest rate swaps
|
|
4.6
|
|
|
(9.0
|
)
|
|
(30.1
|
)
|
|
0.3
|
|
|
Interest expense, net
|
||||
Cross-currency swaps
|
|
(29.0
|
)
|
|
10.7
|
|
|
—
|
|
|
—
|
|
|
Expense (income) on swaps, net
|
|
December 31, 2018
|
|
September 30, 2018
|
||||||||||||||||||||
|
Total
|
|
Level 1
|
|
Level 2
|
|
Total
|
|
Level 1
|
|
Level 2
|
||||||||||||
Assets:
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
Deferred compensation investments
|
$
|
40.1
|
|
|
$
|
40.1
|
|
|
$
|
—
|
|
|
$
|
43.6
|
|
|
$
|
43.6
|
|
|
$
|
—
|
|
Derivative assets
|
4.3
|
|
|
—
|
|
|
4.3
|
|
|
66.4
|
|
|
—
|
|
|
66.4
|
|
||||||
|
$
|
44.4
|
|
|
$
|
40.1
|
|
|
$
|
4.3
|
|
|
$
|
110.0
|
|
|
$
|
43.6
|
|
|
$
|
66.4
|
|
Liabilities:
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
Deferred compensation liabilities
|
$
|
48.0
|
|
|
$
|
—
|
|
|
$
|
48.0
|
|
|
$
|
52.2
|
|
|
$
|
—
|
|
|
$
|
52.2
|
|
Derivative liabilities
|
173.3
|
|
|
—
|
|
|
173.3
|
|
|
141.4
|
|
|
—
|
|
|
141.4
|
|
||||||
|
$
|
221.3
|
|
|
$
|
—
|
|
|
$
|
221.3
|
|
|
$
|
193.6
|
|
|
$
|
—
|
|
|
$
|
193.6
|
|
Balance, September 30, 2018
|
$
|
290.9
|
|
Gains related to assets and liabilities held for sale
|
122.7
|
|
|
Proceeds from the sale of assets and liabilities held for sale
|
(259.8
|
)
|
|
Investment in 8th Avenue, working capital and other adjustments
|
(153.8
|
)
|
|
Balance, December 31, 2018
|
$
|
—
|
|
|
December 31,
2018 |
|
September 30, 2018
|
||||
5.625% Senior Notes maturing January 2028
|
$
|
940.9
|
|
|
$
|
960.9
|
|
5.50% Senior Notes maturing March 2025
|
1,000.0
|
|
|
1,000.0
|
|
||
5.75% Senior Notes maturing March 2027
|
1,299.3
|
|
|
1,326.3
|
|
||
5.00% Senior Notes maturing August 2026
|
1,697.3
|
|
|
1,710.3
|
|
||
8.00% Senior Notes maturing July 2025
|
122.2
|
|
|
122.2
|
|
||
Term Loan
|
1,309.5
|
|
|
2,172.5
|
|
||
Bridge Loan (a)
|
—
|
|
|
—
|
|
||
Capital leases
|
0.2
|
|
|
0.2
|
|
||
|
$
|
6,369.4
|
|
|
$
|
7,292.4
|
|
Less: Current portion of long-term debt
|
(3.4
|
)
|
|
(22.1
|
)
|
||
Debt issuance costs, net
|
(61.0
|
)
|
|
(71.2
|
)
|
||
Plus: Unamortized premium
|
31.5
|
|
|
33.0
|
|
||
Total long-term debt
|
$
|
6,336.5
|
|
|
$
|
7,232.1
|
|
(a)
|
In connection with the 8th Avenue Transactions, the Company classified its Bridge Loan and associated debt issuance costs as held for sale at September 30, 2018. See below for more information about the Bridge Loan. See Note 6 for information about assets and liabilities held for sale.
|
|
|
Repayments of Long-Term Debt
|
|
Loss on Extinguishment of Debt, net
|
||||||||||||||||||
Three Months Ended
December 31, |
|
Issuance or Borrowing
|
|
Principal Amount Repaid
|
|
Debt Repurchased at a Discount
|
|
Premium Paid
|
|
Write-offs of Debt Issuance Costs
|
|
Write-off of Unamortized (Premium)/Discount
|
||||||||||
|
|
Term Loan
|
|
$
|
863.0
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
7.6
|
|
|
$
|
—
|
|
|
|
5.75% Senior Notes
|
|
27.0
|
|
|
(1.5
|
)
|
|
—
|
|
|
0.3
|
|
|
(0.7
|
)
|
|||||
|
|
5.625% Senior Notes
|
|
20.0
|
|
|
(1.3
|
)
|
|
—
|
|
|
0.2
|
|
|
—
|
|
|||||
|
|
5.00% Senior Notes
|
|
13.0
|
|
|
(1.2
|
)
|
|
—
|
|
|
0.1
|
|
|
—
|
|
|||||
|
|
Bridge Loan (a)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
2.6
|
|
|
—
|
|
|||||
2018
|
|
Total
|
|
$
|
923.0
|
|
|
$
|
(4.0
|
)
|
|
$
|
—
|
|
|
$
|
10.8
|
|
|
$
|
(0.7
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||
|
|
6.00% Senior Notes
|
|
$
|
630.0
|
|
|
$
|
—
|
|
|
$
|
30.8
|
|
|
$
|
6.5
|
|
|
$
|
—
|
|
|
|
Term Loan
|
|
5.5
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|||||
2017
|
|
Total
|
|
$
|
635.5
|
|
|
$
|
—
|
|
|
$
|
30.8
|
|
|
$
|
6.5
|
|
|
$
|
—
|
|
(a)
|
In connection with the assumption of the Bridge Loan by 8th Avenue discussed above, the Company recorded a write-off of debt issuance costs during the three months ended December 31, 2018 for costs that were not refunded at closing of the 8th Avenue Transactions.
|
|
North America
|
||||||
|
Three Months Ended
December 31, |
||||||
|
2018
|
|
2017
|
||||
Components of net periodic benefit cost
|
|
|
|
||||
Service cost
|
$
|
1.0
|
|
|
$
|
1.1
|
|
Interest cost
|
1.0
|
|
|
0.9
|
|
||
Expected return on plan assets
|
(1.6
|
)
|
|
(1.1
|
)
|
||
Recognized net actuarial loss
|
—
|
|
|
0.3
|
|
||
Net periodic benefit cost
|
$
|
0.4
|
|
|
$
|
1.2
|
|
|
Other International
|
||||||
|
Three Months Ended
December 31, |
||||||
|
2018
|
|
2017
|
||||
Components of net periodic benefit gain
|
|
|
|
||||
Service cost
|
$
|
1.4
|
|
|
$
|
1.7
|
|
Interest cost
|
4.8
|
|
|
4.8
|
|
||
Expected return on plan assets
|
(7.3
|
)
|
|
(7.8
|
)
|
||
Net periodic benefit gain
|
$
|
(1.1
|
)
|
|
$
|
(1.3
|
)
|
|
Three Months Ended
December 31, |
||||||
|
2018
|
|
2017
|
||||
Components of net periodic benefit cost (gain)
|
|
|
|
||||
Service cost
|
$
|
0.1
|
|
|
$
|
0.2
|
|
Interest cost
|
0.6
|
|
|
0.5
|
|
||
Recognized net actuarial loss
|
—
|
|
|
0.1
|
|
||
Recognized prior service credit
|
(1.2
|
)
|
|
(1.2
|
)
|
||
Net periodic benefit gain
|
$
|
(0.5
|
)
|
|
$
|
(0.4
|
)
|
•
|
Post Consumer Brands: North American RTE cereal business;
|
•
|
Weetabix: the RTE cereal and branded muesli business sold and distributed primarily outside of North America;
|
•
|
Foodservice: primarily egg and potato products;
|
•
|
Refrigerated Retail: refrigerated retail products, inclusive of side dishes, egg, cheese and sausage; and
|
•
|
Active Nutrition: protein shakes and other ready-to-drink products, powders and bars and nutritional supplements.
|
|
|
|
Three Months Ended
December 31, |
||||||
|
|
|
2018
|
|
2017
|
||||
Net Sales
|
|
|
|
||||||
|
Post Consumer Brands
|
$
|
455.3
|
|
|
$
|
432.0
|
|
|
|
Weetabix
|
100.9
|
|
|
99.7
|
|
|||
|
Foodservice
|
408.1
|
|
|
368.9
|
|
|||
|
Refrigerated Retail
|
261.6
|
|
|
141.7
|
|
|||
|
Active Nutrition
|
185.8
|
|
|
186.0
|
|
|||
|
Private Brands
|
—
|
|
|
206.4
|
|
|||
|
Eliminations
|
(0.4
|
)
|
|
(1.6
|
)
|
|||
|
Total
|
$
|
1,411.3
|
|
|
$
|
1,433.1
|
|
|
Segment Profit
|
|
|
|
||||||
|
Post Consumer Brands
|
$
|
84.0
|
|
|
$
|
70.2
|
|
|
|
Weetabix
|
18.9
|
|
|
16.8
|
|
|||
|
Foodservice
|
52.7
|
|
|
45.9
|
|
|||
|
Refrigerated Retail
|
30.5
|
|
|
23.2
|
|
|||
|
Active Nutrition
|
35.2
|
|
|
19.8
|
|
|||
|
Private Brands
|
—
|
|
|
16.9
|
|
|||
|
Total segment profit
|
221.3
|
|
|
192.8
|
|
|||
General corporate expenses and other
|
48.4
|
|
|
28.3
|
|
||||
Gain on sale of business
|
(124.7
|
)
|
|
—
|
|
||||
Interest expense, net
|
59.4
|
|
|
90.5
|
|
||||
Loss on extinguishment of debt, net
|
6.1
|
|
|
37.3
|
|
||||
Expense (income) on swaps, net
|
51.7
|
|
|
(2.7
|
)
|
||||
Earnings before income taxes and equity method loss
|
$
|
180.4
|
|
|
$
|
39.4
|
|
||
Depreciation and amortization
|
|
|
|
||||||
|
Post Consumer Brands
|
$
|
29.5
|
|
|
$
|
30.9
|
|
|
|
Weetabix
|
8.7
|
|
|
7.1
|
|
|||
|
Foodservice
|
27.0
|
|
|
23.9
|
|
|||
|
Refrigerated Retail
|
18.0
|
|
|
7.5
|
|
|||
|
Active Nutrition
|
6.4
|
|
|
6.5
|
|
|||
|
Private Brands
|
—
|
|
|
13.4
|
|
|||
|
|
Total segment depreciation and amortization
|
89.6
|
|
|
89.3
|
|
||
|
Corporate and accelerated depreciation
|
4.0
|
|
|
1.2
|
|
|||
|
Total
|
$
|
93.6
|
|
|
$
|
90.5
|
|
|
|
|
|
|
||||||
|
|
|
|
||||||
Assets
|
December 31,
2018 |
|
September 30,
2018 |
||||||
|
Post Consumer Brands
|
$
|
3,371.5
|
|
|
$
|
3,391.7
|
|
|
|
Weetabix
|
1,807.2
|
|
|
1,853.3
|
|
|||
|
Foodservice and Refrigerated Retail
|
5,116.2
|
|
|
5,132.4
|
|
|||
|
Active Nutrition
|
560.1
|
|
|
559.3
|
|
|||
|
Private Brands
|
—
|
|
|
1,055.3
|
|
|||
|
Corporate
|
429.8
|
|
|
1,065.5
|
|
|||
|
Total
|
$
|
11,284.8
|
|
|
$
|
13,057.5
|
|
ITEM 2.
|
MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
.
|
•
|
Post Consumer Brands: North American ready-to-eat (“RTE”) cereal business;
|
•
|
Weetabix: the RTE cereal and branded muesli business sold and distributed primarily outside of North America;
|
•
|
Foodservice: primarily egg and potato products;
|
•
|
Refrigerated Retail: refrigerated retail products, inclusive of side dishes, egg, cheese and sausage; and
|
•
|
Active Nutrition: protein shakes and other ready-to-drink (“RTD”) products, powders and bars and nutritional supplements.
|
dollars in millions
|
Three Months Ended December 31, 2018
|
||
Post Consumer Brands
|
$
|
(2.0
|
)
|
Weetabix
|
—
|
|
|
Foodservice
|
(1.2
|
)
|
|
Refrigerated Retail
|
—
|
|
|
Active Nutrition
|
(1.1
|
)
|
|
|
$
|
(4.3
|
)
|
|
Three Months Ended December 31,
|
|||||||||||||
|
|
|
|
|
favorable/(unfavorable)
|
|||||||||
dollars in millions
|
2018
|
|
2017
|
|
$ Change
|
|
% Change
|
|||||||
Net Sales
|
$
|
1,411.3
|
|
|
$
|
1,433.1
|
|
|
$
|
(21.8
|
)
|
|
(2
|
)%
|
|
|
|
|
|
|
|
|
|||||||
Operating Profit
|
$
|
293.9
|
|
|
$
|
161.0
|
|
|
$
|
132.9
|
|
|
83
|
%
|
Interest expense, net
|
59.4
|
|
|
90.5
|
|
|
31.1
|
|
|
34
|
%
|
|||
Loss on extinguishment of debt, net
|
6.1
|
|
|
37.3
|
|
|
31.2
|
|
|
84
|
%
|
|||
Expense (income) on swaps, net
|
51.7
|
|
|
(2.7
|
)
|
|
(54.4
|
)
|
|
(2,015
|
)%
|
|||
Other income, net
|
(3.7
|
)
|
|
(3.5
|
)
|
|
0.2
|
|
|
6
|
%
|
|||
Income tax expense (benefit)
|
43.8
|
|
|
(255.8
|
)
|
|
(299.6
|
)
|
|
(117
|
)%
|
|||
Equity method loss, net of tax
|
10.7
|
|
|
—
|
|
|
(10.7
|
)
|
|
n/a
|
|
|||
Less: Net earnings attributable to noncontrolling interest
|
0.3
|
|
|
0.3
|
|
|
—
|
|
|
—
|
%
|
|||
Net Earnings
|
$
|
125.6
|
|
|
$
|
294.9
|
|
|
$
|
(169.3
|
)
|
|
(57
|
)%
|
|
Three Months Ended December 31,
|
|||||||||||||
|
|
|
|
|
favorable/(unfavorable)
|
|||||||||
dollars in millions
|
2018
|
|
2017
|
|
$ Change
|
|
% Change
|
|||||||
Net Sales
|
$
|
455.3
|
|
|
$
|
432.0
|
|
|
$
|
23.3
|
|
|
5
|
%
|
Segment Profit
|
$
|
84.0
|
|
|
$
|
70.2
|
|
|
$
|
13.8
|
|
|
20
|
%
|
Segment Profit Margin
|
18
|
%
|
|
16
|
%
|
|
|
|
|
|
Three Months Ended December 31,
|
|||||||||||||
|
|
|
|
|
favorable/(unfavorable)
|
|||||||||
dollars in millions
|
2018
|
|
2017
|
|
$ Change
|
|
% Change
|
|||||||
Net Sales
|
$
|
100.9
|
|
|
$
|
99.7
|
|
|
$
|
1.2
|
|
|
1
|
%
|
Segment Profit
|
$
|
18.9
|
|
|
$
|
16.8
|
|
|
$
|
2.1
|
|
|
13
|
%
|
Segment Profit Margin
|
19
|
%
|
|
17
|
%
|
|
|
|
|
|
Three Months Ended December 31,
|
|||||||||||||
|
|
|
|
|
favorable/(unfavorable)
|
|||||||||
dollars in millions
|
2018
|
|
2017
|
|
$ Change
|
|
% Change
|
|||||||
Net Sales
|
$
|
408.1
|
|
|
$
|
368.9
|
|
|
$
|
39.2
|
|
|
11
|
%
|
Segment Profit
|
$
|
52.7
|
|
|
$
|
45.9
|
|
|
$
|
6.8
|
|
|
15
|
%
|
Segment Profit Margin
|
13
|
%
|
|
12
|
%
|
|
|
|
|
|
Three Months Ended December 31,
|
|||||||||||||
|
|
|
|
|
favorable/(unfavorable)
|
|||||||||
dollars in millions
|
2018
|
|
2017
|
|
$ Change
|
|
% Change
|
|||||||
Net Sales
|
$
|
261.6
|
|
|
$
|
141.7
|
|
|
$
|
119.9
|
|
|
85
|
%
|
Segment Profit
|
$
|
30.5
|
|
|
$
|
23.2
|
|
|
$
|
7.3
|
|
|
31
|
%
|
Segment Profit Margin
|
12
|
%
|
|
16
|
%
|
|
|
|
|
|
Three Months Ended December 31,
|
|||||||||||||
|
|
|
|
|
favorable/(unfavorable)
|
|||||||||
dollars in millions
|
2018
|
|
2017
|
|
$ Change
|
|
% Change
|
|||||||
Net Sales
|
$
|
185.8
|
|
|
$
|
186.0
|
|
|
$
|
(0.2
|
)
|
|
—
|
%
|
Segment Profit
|
$
|
35.2
|
|
|
$
|
19.8
|
|
|
$
|
15.4
|
|
|
78
|
%
|
Segment Profit Margin
|
19
|
%
|
|
11
|
%
|
|
|
|
|
|
Three Months Ended December 31,
|
|||||||||||||
|
|
|
|
|
favorable/(unfavorable)
|
|||||||||
dollars in millions
|
2018
|
|
2017
|
|
$ Change
|
|
% Change
|
|||||||
General corporate expenses and other
|
$
|
48.4
|
|
|
$
|
28.3
|
|
|
$
|
(20.1
|
)
|
|
(71
|
)%
|
•
|
$625.0 million principal value bridge loan assumed by 8th Avenue in connection with the 8th Avenue Transactions, releasing us from any obligations thereunder while we retained the proceeds from the bridge loan;
|
•
|
$250.0 million received from THL as part of the 8th Avenue Transactions;
|
•
|
$863.0 million principal value paid on our existing term loan using the $875.0 million of proceeds received from the 8th Avenue Transactions, net of debt issuance costs paid related to the bridge loan and other transaction costs;
|
•
|
$60.0 million
outstanding principal value repurchased and retired of our 5.625% senior notes due in January 2028, 5.75% senior notes due in March 2027 and 5.00% senior notes due in August 2026;
|
•
|
0.3 million
shares of our common stock repurchased at an average share price of
$88.14
per share for a total cost of
$25.3 million
, including broker’s commissions; and
|
•
|
$257.6 million
of payments made to former holders of Bob Evans common stock who had demanded appraisal of their shares under Delaware law and had not yet been paid for their shares.
|
|
Three Months Ended
December 31, |
||||||
dollars in millions
|
2018
|
|
2017
|
||||
Cash provided by operating activities
|
$
|
238.7
|
|
|
$
|
204.5
|
|
Cash provided by (used in) investing activities
|
201.5
|
|
|
(47.8
|
)
|
||
Cash (used in) provided by financing activities
|
(1,199.6
|
)
|
|
259.6
|
|
||
Effect of exchange rate changes on cash, cash equivalents and restricted cash
|
(1.6
|
)
|
|
0.7
|
|
||
Net (decrease) increase in cash, cash equivalents and restricted cash
|
$
|
(761.0
|
)
|
|
$
|
417.0
|
|
•
|
our high leverage, our ability to obtain additional financing (including both secured and unsecured debt) and our ability to service our outstanding debt (including covenants that restrict the operation of our business);
|
•
|
our ability to continue to compete in our product categories and our ability to retain our market position and favorable perceptions of our brands;
|
•
|
our ability to anticipate and respond to changes in consumer preferences and trends and introduce new products;
|
•
|
the possibility that we may not be able to consummate the initial public offering of our Active Nutrition business on the expected timeline or at all, that we may not be able to create value in our Active Nutrition business through such transaction or that the pursuit of such transaction could be disruptive to us and our Active Nutrition business;
|
•
|
our ability to identify, complete and integrate acquisitions and manage our growth;
|
•
|
our ability to promptly and effectively realize the expected synergies of our acquisition of Bob Evans within the expected timeframe or at all;
|
•
|
higher freight costs, significant volatility in the costs or availability of certain raw materials, commodities or packaging used to manufacture our products or higher energy costs;
|
•
|
impairment in the carrying value of goodwill or other intangibles;
|
•
|
our ability to successfully implement business strategies to reduce costs;
|
•
|
allegations that our products cause injury or illness, product recalls and withdrawals and product liability claims and other litigation;
|
•
|
legal and regulatory factors, such as compliance with existing laws and regulations and changes to and new laws and regulations affecting our business, including current and future laws and regulations regarding food safety, advertising and labeling and animal feeding and housing operations;
|
•
|
the loss of, a significant reduction of purchases by or the bankruptcy of a major customer;
|
•
|
consolidations in the retail and foodservice distribution channels;
|
•
|
losses incurred in the appraisal proceedings brought in connection with our acquisition of Bob Evans by former Bob Evans stockholders who demanded appraisal of their shares;
|
•
|
the ultimate impact litigation or other regulatory matters may have on us;
|
•
|
disruptions or inefficiencies in the supply chain, including as a result of our reliance on third party manufacturers for certain of our products;
|
•
|
changes in weather conditions, natural disasters, agricultural diseases and pests and other events beyond our control;
|
•
|
our ability to successfully collaborate with the private equity firm Thomas H. Lee Partners, L.P., whose affiliates invested with us in 8th Avenue;
|
•
|
costs associated with Bob Evans’s obligations in connection with the sale and separation of its restaurant business in April 2017, which occurred prior to our acquisition of Bob Evans, including certain indemnification obligations under the restaurants sale agreement and Bob Evans’s payment and performance obligations as a guarantor for certain leases;
|
•
|
the ability of our and our customers’ private brand products to compete with nationally branded products;
|
•
|
our ability to successfully operate our international operations in compliance with applicable laws and regulations;
|
•
|
changes in economic conditions, disruptions in the United States and global capital and credit markets, changes in interest rates and fluctuations in foreign currency exchange rates;
|
•
|
the possibility of, or the occurrence of, a prolonged shutdown of the United States federal government, including any uncertainties resulting therefrom, any adverse impacts on the financial markets and economic conditions in the United States or worldwide and any regulatory or other delays occurring during or after a shutdown;
|
•
|
the impact of the United Kingdom’s exit from the European Union (commonly known as “Brexit”) on us and our operations;
|
•
|
changes in estimates in critical accounting judgments, including those based on tax reform;
|
•
|
loss of key employees, labor strikes, work stoppages or unionization efforts;
|
•
|
losses or increased funding and expenses related to our qualified pension or other postretirement plans;
|
•
|
costs, business disruptions and reputational damage associated with information technology failures, cybersecurity incidents or information security breaches;
|
•
|
our ability to protect our intellectual property and other assets;
|
•
|
significant differences in our and 8th Avenue’s actual operating results from our guidance regarding our and 8th Avenue’s future performance;
|
•
|
our ability to satisfy the requirements of Section 404 of the Sarbanes-Oxley Act of 2002; and
|
•
|
other risks and uncertainties included under “Risk Factors” in this report and in our Annual Report on Form 10-K for the fiscal year ended September 30, 2018, filed with the SEC on November 16, 2018.
|
PART II.
|
OTHER INFORMATION.
|
ITEM 1.
|
LEGAL PROCEEDINGS.
|
ITEM 1A.
|
RISK FACTORS.
|
ITEM 2.
|
UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS.
|
Period
|
Total Number of Shares Purchased (a)
|
Average Price Paid per Share (b)
|
Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs (c)
|
Approximate Dollar Value of Shares that May Yet be Purchased Under the Plans or Programs (b) (c)
|
||||||
October 1, 2018-October 31, 2018
|
55,220
|
|
|
$88.16
|
|
55,220
|
|
|
$303,172,058
|
|
November 1, 2018- November 30, 2018
|
22,567
|
|
|
$89.52
|
|
22,567
|
|
|
$301,151,925
|
|
December 1, 2018- December 31, 2018
|
209,918
|
|
|
$87.96
|
|
209,918
|
|
|
$282,687,738
|
|
Total
|
287,705
|
|
|
$88.12
|
|
287,705
|
|
|
$282,687,738
|
|
(a)
|
The total number of shares purchased includes: (i) shares purchased on the open market and (ii) shares purchased pursuant to a Rule 10b5-1 plan.
|
(b)
|
Does not include broker’s commissions.
|
(c)
|
On May 2, 2018, our Board of Directors authorized the Company to repurchase up to $350,000,000 of shares of our common stock to begin on May 7, 2018. The authorization expires on May 7, 2020.
|
ITEM 6.
|
EXHIBITS.
|
Exhibit No.
|
|
Description
|
|
|
|
‡2.4
|
|
|
|
|
|
3.1
|
|
|
|
|
|
3.2
|
|
|
|
|
|
3.3
|
|
|
|
|
|
4.1
|
|
|
|
|
|
4.2
|
|
|
|
|
|
4.3
|
|
|
|
|
|
4.4
|
|
|
|
|
|
4.5
|
|
|
|
|
|
4.6
|
|
|
|
|
|
4.7
|
|
|
|
|
|
10.52
|
|
|
|
|
|
10.53
|
|
|
|
|
|
10.54
|
|
|
|
|
|
†10.55
|
|
|
|
|
|
Exhibit No.
|
|
Description
|
†10.56
|
|
|
|
|
|
†10.57
|
|
|
|
|
|
†10.58
|
|
|
|
|
|
†10.59
|
|
|
|
|
|
†10.60
|
|
|
|
|
|
31.1
|
|
|
|
|
|
31.2
|
|
|
|
|
|
32.1
|
|
|
|
|
|
101
|
|
Interactive Data File (Form 10-Q for the quarterly period ended December 31, 2018 filed in XBRL). The financial information contained in the XBRL-related documents is “unaudited” and “unreviewed.”
|
†
|
These exhibits constitute management contracts, compensatory plans and arrangements.
|
‡
|
Schedules and exhibits have been omitted pursuant to Item 601(b)(2) of Regulation S-K. The Company hereby undertakes to furnish copies of any of the omitted schedules and exhibits upon request by the U.S. Securities and Exchange Commission.
|
|
|
POST HOLDINGS, INC.
|
|
Date:
|
February 1, 2019
|
By:
|
/s/ Jeff A. Zadoks
|
|
|
|
Jeff A. Zadoks
|
|
|
|
EVP and Chief Financial Officer (Principal Financial Officer)
|
Grant Date
|
Type of Award
|
Number of RSUs Outstanding
|
11/14/2016
|
RSU
|
2,667
|
11/13/2017
|
RSU
|
5,541
|
•
|
Date of Exchange:
The cancellation of the Post Equity is expected to occur as soon administratively practicable following the Grant Date (as such term is defined in the Award Agreement) of 8th Avenue Stock Options.
|
•
|
Amount to be Exchanged:
You may only elect to exchange all or none of your Post Equity.
|
•
|
Term and Expiration of Exchange Offer:
You must return an executed Acceptance form on or before January 4, 2019.
|
•
|
Rights under your Post Equity Grants:
If you elect to exchange your Post Equity, all of the award agreements governing the Post Equity and the Post Equity represented thereby will be fully cancelled, and you will have no remaining rights under the cancelled agreements.
|
•
|
Terms and Conditions of the 8th Avenue Stock Options:
All terms and conditions of the new 8th Avenue Stock Options will be included in the new Award Agreement, or referenced in the new Award Agreement and included in the 8th Avenue Plan. Note that the 8th Avenue Stock Options are not RSU awards and will be subject to different vesting and forfeiture provisions, which are included in the 8th Avenue Plan and the Award Agreement. By electing to exchange your Post Equity, you will be deemed to have consented to such terms and conditions.
|
|
SIGNATURE OF POST EQUITY HOLDER
|
|
|
|
|
|
X
|
/s/ James E. Dwyer, Jr.
|
|
|
|
|
Date: 12, 18, 2018
|
|
|
|
|
|
Print Name: James E. Dwyer, Jr.
|
|
|
|
|
|
Address: XXXXXXXXXXXXX
|
|
|
XXXXXXXXXXXXXXXXXXX
|
|
|
|
|
|
Telephone No. (with area code): XXX XXX XXXX
|
1.
|
Execution
.
The Award shall not be effective unless and until the Participant has executed this Award Agreement and executed a joinder to the Shareholders Agreement.
|
2.
|
Vesting
.
The Options shall vest upon the schedule set forth below, provided the Participant is, and has been, continuously employed by or providing services to the Company or any of its Subsidiaries from the date of grant through each such vesting date:
|
i.
|
144,887.380 Options will be subject to time-vesting only (the “
Time-Vested Options
”) and will vest over the five (5) year period beginning on the date of grant with 40.0% of the Time-Vested Options vesting on the second (2nd) anniversary of the date of grant and 20% vesting on each anniversary thereafter, such that all Time-Vested Options shall be vested as of the fifth (5th) anniversary of the date of grant, if the Participant is, and has been, continuously employed by or providing services to the Company or any of its Subsidiaries from the date of grant through each such vesting date.
|
ii.
|
190,907.810 Options will be subject to time- and performance-based vesting criteria, both of which must be satisfied for such Options to vest and become exercisable (the “
Performance-Based Options
”). The time-based vesting criteria for the Performance-Based Options will match the vesting schedule of the Time-Vested Options (including the requirement that the Participant remain continuously employed on each respective vesting date). The Performance-Based Options will performance vest as follows based on the level of Investor IRR achieved by the Investor as of any applicable Measurement Date:
|
3.
|
Change in Control
.
Notwithstanding the foregoing, the service requirement of all Options shall be deemed satisfied as of immediately prior to (but subject to the consummation of) a Change in Control if the respective Participant is, and has been, continuously employed by and continues to provide services to the Company and/or any of its Subsidiaries through the date of such consummation, and as otherwise set forth in an Award Agreement. For the avoidance of doubt, the Performance-Based Options shall only fully vest and become exercisable to the extent that the applicable performance targets set forth above have also been achieved. Any Performance-Based Options that will not performance-vest (or that have not performance vested) on a Change in Control shall terminate and be canceled immediately before such Change in Control, unless otherwise determined by the Board. For the avoidance of doubt, upon an IPO of the Company or any of its Subsidiaries or any successor to any of them, all Options will continue to vest on the original time-vesting schedule set forth above.
|
4.
|
Restrictive Covenants.
The Company and its Subsidiaries operate in a highly sensitive and competitive commercial environment. As part of Participant’s employment and/or service with the Company and its Subsidiaries, Participants will be exposed to highly confidential and sensitive information regarding the Company’s and its Subsidiaries’ business operations, including corporate strategy, pricing and other market information, know-how, trade secrets, and valuable customer, supplier, strategic partner, licensee, licensor, lessor, regulatory and employee relationships. It is critical that the Company take all necessary steps to safeguard its legitimate protectable interests in such information and to prevent any of its competitors or any other persons from obtaining any such information. Therefore, as consideration for the Company’s agreement to grant Awards to
Participant, Participant agrees to be bound by the following restrictive covenants:
|
a.
|
Confidentiality.
Participant shall not, for any purpose whatsoever, other than to the extent necessary to render services to the Company or its Subsidiaries in good faith, required by law, or with the express prior written consent of the Company, use, disclose, or divulge to a third party or use for Participant’s personal benefit or for the benefit of a third party, at any time, either during Participant’s employment or services with the Company or its Subsidiaries or thereafter, any Confidential Information of which Participant is or becomes aware, whether or not such information is developed by Participant. Participant will treat all Confidential Information as confidential and take all reasonable and appropriate steps to safeguard all Confidential Information and to protect it against disclosure, misuse, espionage, loss and theft. Participant shall deliver to the Company at Participant’s Termination Date, or at any other time the Company may request, all memoranda, notes, agreements, client lists, plans, records, reports, computer tapes and software and other documents and data (and all copies or reproductions thereof) relating to the Confidential Information, Work Product or the business of the Company or any of its Subsidiaries which Participant may then possess or have under Participant’s control. As used herein, the term “Confidential Information” means information that is not generally known to the public and that is used, developed or obtained by the Company or its Subsidiaries in connection with their business, including but not limited to (i) information, observations and data obtained by Participant while employed by or providing services to the Company or its Subsidiaries concerning the business or affairs of the Company or its Subsidiaries, (ii) products or services, (iii) fees, costs and pricing structures, (iv) designs, (v) analyses, (vi) drawings, photographs and reports, (vii) computer software (including source code, executable code, algorithms, pseudocode, firmware, interfaces, data, databases, and documentation), including operating systems, applications and program listings or any portions or logic comprising said software, (viii) flow charts, manuals and documentation, (ix) data bases, (x) accounting and business methods, (xi) inventions, devices, new Developments, methods and processes, whether patentable or unpatentable and whether or not reduced to practice, (xii) customers and clients and customer or client lists and terms of contracts with clients and customers (xiii) other copyrightable works, (xiv) all production, programming, manufacturing, engineering, and distribution processes or techniques, technology and trade secrets, and (xv) all similar and related information in whatever form or medium. Notwithstanding the foregoing, the term “Confidential Information” shall not include any information that Participant can demonstrate by written proof was generally available to the public at the time it was disclosed to such Participant or subsequently becomes generally available to the public other than as a result of a disclosure by such Participant in violation of the Restrictive Covenants, provided that Confidential Information will not be deemed to have been generally available merely because individual portions of the information have been separately published or otherwise made generally available to the public, but only if all material features comprising such information have been made generally available to the public in combination. The covenants made shall continue perpetually, including after Participant’s Termination Date.
|
b.
|
Whistleblower Protection.
Nothing in this Award Agreement prohibits the Participants from reporting possible violations of United States federal law or regulation to any governmental agency or entity, including but not limited to, the United States Department of Justice, the United States Securities and Exchange Commission, the United States Congress, and any Inspector General of any United States federal agency, or making other disclosures that are protected under the whistleblower provisions of United States federal, state or local law or regulation; provided, that the Participants will use his or her reasonable best efforts to (1) disclose only information that is reasonably related to such possible violations or that is requested by such agency or entity, and (2) request that such agency or entity treat such information as confidential. Participants do not need the prior authorization from the Company to make any such reports or disclosures and is not required to notify the Company that the Participants have made such reports or disclosures. This Award Agreement does not limit the Participants’ right to receive an award for information provided to any governmental agency or entity.
|
c.
|
Assignment of Inventions.
Any copyrightable work falling within the definition of Work Product shall be deemed a “work-made-for-hire” under the copyright laws of the United States (17 U.S.C. 101 et seq.), and ownership of all rights therein shall vest in the Company or its Subsidiaries, as applicable, from the moment of fixation. In the event that any Work Product is deemed not to be a “work-made-for-hire,” or if other rights may at any time be embodied in any Work Product, Participant hereby assigns and transfers, and agrees to assign and transfer to the Company and its legal successors and assigns, the entire right, title, and interest in and to such Work Product. Participant hereby waives, to the extent permitted by applicable law, all “moral rights” Participant has in and to the Work Product. Participant will promptly disclose any Work Product as may be susceptible of such manner of communication to the Company and perform all actions reasonably requested by the Company (whether before or after Participant’s Termination Date) to establish and confirm such ownership (including, without limitation, the execution and delivery of assignments, affidavits, declarations, oaths, exhibits, consents, powers of attorney and other instruments and documentation) and to provide reasonable assistance to the Company or any of its Subsidiaries in connection with the application and prosecution of any applications for any intellectual property rights or reissues thereof or in the prosecution or defense of interferences relating to any Work Product. Should the Company be unable to secure Participant’s signature on any document necessary to apply for, prosecute, obtain, or enforce any patent, copyright, or other right or protection relating to any Work Product, whether due to Participant’s mental or physical incapacity or any other cause, Participant hereby irrevocably designates and appoints the Company and each of its duly authorized officers and agents as Participant’s agent and attorney in fact, to act for and in Participant’s behalf and stead, to execute and file any such document, and to do all other lawfully permitted acts to further the prosecution, issuance, and enforcement of patents, copyrights, or other rights or protections with the same force and effect as if executed and delivered by Participant.
|
d.
|
Trade Secrets.
18 U.S.C. § 1833(b) provides: “An individual shall not be held criminally or civilly liable under any Federal or State trade secret law for the disclosure of a trade secret that (A) is made (i) in confidence to a Federal, State, or local government official, either directly or indirectly, or to an attorney; and (ii) solely for the purpose of reporting or investigating a suspected violation of law; or (B) is made in a complaint or other document filed in a lawsuit or other proceeding, if such filing is made under seal.” Nothing in this Award Agreement is intended to conflict with 18 U.S.C. § 1833(b) or create liability for disclosures of trade secrets that are expressly allowed by 18 U.S.C. § 1833(b). Accordingly, the Participants and the Company have the right to disclose in confidence trade secrets to federal, state, and local government officials, or to an attorney, for the sole purpose of reporting or investigating a suspected violation of law. The Participants and the Company also have the right to disclose trade secrets in a document filed in a lawsuit or other proceeding, but only if the filing is made under seal and protected from public disclosure.
|
e.
|
Notice of Statutory Exception.
Notwithstanding anything to the contrary contained in the Award Agreement, Work Product shall not include any invention developed entirely on Participant’s own time without using any equipment, supplies, facilities, or trade secrets of the Company or any of its Subsidiaries, unless such invention (a) relates at the time of conception or reduction to practice to the business of the Company or its Subsidiaries or its and actual or demonstrably anticipated research or development of the Company or its Subsidiaries, or (b) results from any work performed by Participant for Company or any of its Subsidiaries.
|
f.
|
Non-Competition; Non-Solicitation.
Participant acknowledges and agrees with the Company that during the course of Participant’s involvement and/or employment with the Company or its Subsidiaries, Participant has had and will continue to have the opportunity to develop relationships with existing employees, vendors, suppliers, customers, strategic partners, licensees, licensors, lessors and other business associates of the Company and its Subsidiaries which relationships constitute goodwill of the Company and its Subsidiaries, and the Company and its Subsidiaries would be irreparably damaged if Participant were to take actions that would damage or misappropriate such goodwill. Accordingly, Participant agrees as follows: Participant acknowledges that the Company and its Subsidiaries currently conduct their business throughout the United States (such geographical territory, including as it expands from time to time, the “
Territory
”). For purposes hereof, the “Territory” shall also include any United States or international market in which the Company or any of its Subsidiaries conducts its business at the time of Participant’s Termination Date. Accordingly, during the period of such Participant’s employment or service with the Company and its Subsidiaries plus two (2) years after such Participant’s Termination Date (the “
Non-Competition Period
”), Participant shall not, directly or indirectly, own, manage, engage in, operate, control, work for, consult with, render services for, or participate in or acquire, maintain any interest in (proprietary or otherwise) any Competitive Business within the Territory, whether for or by Participant or as a representative for or on behalf of any other person or entity. For purposes herein, “
Competitive Business
” shall mean any business that, directly or indirectly, produces, develops, markets, or sells any type of food products produced, developed, marketed or sold by the Company and its Subsidiaries upon the Participant’s Termination Date.
|
g.
|
Participant agrees that, during the period of such Participant’s employment or service with the Company and its Subsidiaries plus eighteen (18) months after such Participant’s Termination Date, he will not, directly or indirectly, in any manner (whether on his own account, as an owner, operator, manager, consultant, officer, director, employee, investor, agent or otherwise), (A) solicit, recruit, induce or attempt to solicit, recruit or induce any employee of the Company or any of its Subsidiaries to leave the employ or service of the Company or any of its Subsidiaries, or in any way interfere with the relationship between the Company or its Subsidiaries and any such employee or other service provider (provided, that a general solicitation advertisement, posting, or similar job solicitation process or sending employee searches by headhunter/search firms not targeting any such Person shall not be a breach of the
Non-Competition or Non-Solicitation, or (B) hire, engage or enter into any business relationship with any Person employed or engaged by the Company or any of its Subsidiaries as a vice president or more senior executive, or who was employed or engaged by the Company or any of its Subsidiaries as a vice president or more senior executive at any time during the six-month period immediately prior to the Participant’s Termination Date.
|
h.
|
Non-Disparagement.
Participant agrees not to make negative comments or otherwise disparage the Company and its Subsidiaries or their officers, directors, employees, shareholders, members, agents or products other than in the good faith performance of Participant’s duties to the Company while Participant is employed by and no longer provides services to the Company. The foregoing shall not be violated by truthful statements in response to legal process, required governmental testimony or filings, or administrative or arbitral proceedings (including, without limitation, depositions in connection with such proceedings).
|
i.
|
No Restriction on Earning a Living.
Participant hereby acknowledges that the provisions of the Non-Competition and Non-Solicitation do not preclude Participant from earning a livelihood, nor do they unreasonably impose limitations on Participant’s ability to earn a living. In addition, Participant hereby acknowledges that the potential harm to the Company and/or its Subsidiaries of non-enforcement of the Non-Competition and Non-Solicitation outweighs any harm to Participant of enforcement (by injunction or otherwise) of the Non-Competition and Non-Solicitation against Participant. If any portion of the provisions of the Non-Competition and Non-Solicitation is found to be invalid or unenforceable by a court of competent jurisdiction because its duration, territory, definition of activities covered, or definition of information covered is considered to be unreasonable in scope, the invalid or unenforceable term shall be redefined, or a new enforceable term provided, such that the intent of the Company and Participant in agreeing to the provisions of the Non-Competition and Non-Solicitation will not be impaired and the provision in question shall be enforceable to the fullest extent of applicable law.
|
j.
|
Additional Acknowledgements; Remedies.
Participant acknowledges that the restrictions contained in the Restrictive Covenants are reasonable and necessary to protect the legitimate interests of the Company and its Subsidiaries and that the Company would not have entered into the Plan or any Award Agreement in the absence of such restrictions. Participant also acknowledges that any breach by Participant of the Restrictive Covenants will cause continuing and irreparable injury to the Company and its Subsidiaries for which monetary damages would not be an adequate remedy. Participant shall not, in any action or proceeding to enforce any of the provisions of the Plan or Award Agreement, assert any claim or defense that an adequate remedy at law exists or that these Restrictive Covenants are unreasonable or otherwise not enforceable in accordance with its terms. In the event that, notwithstanding the foregoing, Participant challenges the reasonableness or enforceability of the restrictions contained in these Restrictive Covenants, Participant shall pay the attorneys’ fees of the Company and/or its Subsidiaries, as applicable. In the event of such breach by Participant, the Company or any of its Subsidiaries shall have the right to enforce the provisions of these Restrictive Covenants by seeking injunctive or other relief in any court, and the Award Agreement shall not in any way limit remedies of law or in equity otherwise available to such entity. The periods of time set forth in these Restrictive Covenants shall not include, and shall be deemed extended by, any time required for litigation to enforce the relevant covenant periods, provided that the Company or any of its Subsidiaries is successful on the merits in any such litigation. The “time required for litigation” is herein defined to mean the period of time from the earlier of Participant's first breach of such covenants or service of process upon Participant through the expiration of all appeals related to such litigation.
|
k.
|
Survival of Provisions.
The obligations contained in the Restrictive Covenants shall survive the termination of Participant’s employment or service with the Company and its Subsidiaries and shall be fully enforceable thereafter.
|
|
8TH AVENUE FOOD & PROVISIONS, INC.
|
|
|
|
|
|
By:
|
/s/ John P. Lavey
|
|
Name:
|
John P. Lavey
|
|
Title:
|
Associate General Counsel, Secretary
|
PARTICIPANT
|
|
|
|
|
|
Accepted and Agreed:
|
|
|
|
|
|
/s/ James E. Dwyer, Jr.
|
|
|
Name:
|
James Dwyer
|
|
1.
|
I have reviewed this quarterly report on Form 10-Q of Post Holdings, Inc.;
|
2.
|
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
|
3.
|
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
|
4.
|
The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
|
a.
|
Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
|
b.
|
Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
|
c.
|
Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
|
d.
|
Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
|
5.
|
The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
|
a.
|
All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
|
b.
|
Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
|
Date:
|
|
February 1, 2019
|
|
By:
|
/s/ Robert V. Vitale
|
|
|
|
|
|
Robert V. Vitale
|
|
|
|
|
|
President and Chief Executive Officer
|
1.
|
I have reviewed this quarterly report on Form 10-Q of Post Holdings, Inc.;
|
2.
|
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
|
3.
|
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
|
4.
|
The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
|
a.
|
Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
|
b.
|
Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
|
c.
|
Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
|
d.
|
Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
|
5.
|
The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
|
a.
|
All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
|
b.
|
Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
|
Date:
|
|
February 1, 2019
|
|
By:
|
/s/ Jeff A. Zadoks
|
|
|
|
|
|
Jeff A. Zadoks
|
|
|
|
|
|
EVP and Chief Financial Officer
|
(a)
|
the quarterly report on Form 10-Q for the period ended
December 31, 2018
, filed on the date hereof with the Securities and Exchange Commission (the "Report"), fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and
|
(b)
|
information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
|
Date:
|
|
February 1, 2019
|
|
By:
|
/s/ Robert V. Vitale
|
|
|
|
|
|
Robert V. Vitale
|
|
|
|
|
|
President and Chief Executive Officer
|
(a)
|
the quarterly report on Form 10-Q for the period ended
December 31, 2018
, filed on the date hereof with the Securities and Exchange Commission (the "Report"), fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and
|
(b)
|
information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
|
Date:
|
|
February 1, 2019
|
|
By:
|
/s/ Jeff A. Zadoks
|
|
|
|
|
|
Jeff A. Zadoks
|
|
|
|
|
|
EVP and Chief Financial Officer
|